CTI BioPharma Corp. (Nasdaq: CTIC) fell to a loss for the fourth quarter of 27 cents per share compared to earnings of 8 cents per share a year earlier as revenue plunged. The stock price tumbled 63 cents to $1.97.
CTI BioPharma falls to loss
March 13, 2015 at 06:34 AM EDT
